Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Equity Average (2018 - 2025)

Health Catalyst's Equity Average history spans 8 years, with the latest figure at $288.9 million for Q4 2025.

  • For Q4 2025, Equity Average fell 19.79% year-over-year to $288.9 million; the TTM value through Dec 2025 reached $288.9 million, down 19.79%, while the annual FY2025 figure was $305.5 million, 16.55% down from the prior year.
  • Equity Average reached $288.9 million in Q4 2025 per HCAT's latest filing, down from $339.7 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $535.7 million in Q4 2021 to a low of $272.4 million in Q2 2021.
  • Average Equity Average over 5 years is $386.3 million, with a median of $372.8 million recorded in 2023.
  • Peak YoY movement for Equity Average: soared 86.08% in 2021, then decreased 19.79% in 2025.
  • A 5-year view of Equity Average shows it stood at $535.7 million in 2021, then dropped by 19.26% to $432.5 million in 2022, then decreased by 13.37% to $374.7 million in 2023, then dropped by 3.88% to $360.1 million in 2024, then fell by 19.79% to $288.9 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Equity Average are $288.9 million (Q4 2025), $339.7 million (Q3 2025), and $362.2 million (Q2 2025).